Essner R - Search Results

1

A Comparison of 3 tumor markers (MIA, TA90IC, S100B) in stage III melanoma patients.

Faries MB, Gupta RK, Ye X, Lee C, Yee R, Leopoldo Z, Essner R, Foshag LJ, Elashoff D, Morton DL. Faries MB, et al. Among authors: essner r. Cancer Invest. 2007 Aug;25(5):285-93. doi: 10.1080/07357900701208634. Cancer Invest. 2007. PMID: 17661202

2

Age-related next-generation sequencing mutational analysis in 1196 melanomas.

Santamaria-Barria JA, Matsuba C, Khader A, Scholar AJ, Garland-Kledzik M, Fischer TD, Essner R, Salomon MP, Mammen JMV, Goldfarb M. Santamaria-Barria JA, et al. Among authors: essner r. J Surg Oncol. 2023 Jun;127(7):1187-1195. doi: 10.1002/jso.27239. Epub 2023 Mar 20. J Surg Oncol. 2023. PMID: 36938777

3

Production of tumor necrosis factor alpha and interferon gamma in interleukin-2-treated melanoma patients: correlation with clinical toxicity.

Economou JS, Hoban M, Lee JD, Essner R, Swisher S, McBride W, Hoon DB, Morton DL. Economou JS, et al. Among authors: essner r. Cancer Immunol Immunother. 1991;34(1):49-52. doi: 10.1007/BF01741324. Cancer Immunol Immunother. 1991. PMID: 1760811 Free PMC article. Clinical Trial.

4

Differential effects of granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor on tumor necrosis factor and interleukin-1 production in human monocytes.

Essner R, Rhoades K, McBride WH, Morton DL, Economou JS. Essner R, et al. J Clin Lab Immunol. 1990 Aug;32(4):161-6. J Clin Lab Immunol. 1990. PMID: 1966932

5

Genetic analysis of the human tumor necrosis factor alpha/cachectin promoter region in a macrophage cell line.

Economou JS, Rhoades K, Essner R, McBride WH, Gasson JC, Morton DL. Economou JS, et al. Among authors: essner r. J Exp Med. 1989 Jul 1;170(1):321-6. doi: 10.1084/jem.170.1.321. J Exp Med. 1989. PMID: 2746161 Free PMC article.

6

Tumour necrosis factor production by IL-2-activated macrophages in vitro and in vivo.

Economou JS, McBride WH, Essner R, Rhoades K, Golub S, Holmes EC, Morton DL. Economou JS, et al. Among authors: essner r. Immunology. 1989 Aug;67(4):514-9. Immunology. 1989. PMID: 2788610 Free PMC article.

7

Prognostic significance of melanoma arising in the scalp.

Essner R, Wong JH, Economou JS, Morton DL. Essner R, et al. Am J Surg. 1988 Oct;156(4):314-7. doi: 10.1016/s0002-9610(88)80302-7. Am J Surg. 1988. PMID: 3177758

8

Interleukin 4 regulates G1 cell cycle progression in gastric carcinoma cells.

Morisaki T, Uchiyama A, Yuzuki D, Essner R, Morton DL, Hoon DS. Morisaki T, et al. Among authors: essner r. Cancer Res. 1994 Feb 15;54(4):1113-8. Cancer Res. 1994. PMID: 8313369

9

Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanomas of the head and neck.

Morton DL, Wen DR, Foshag LJ, Essner R, Cochran A. Morton DL, et al. Among authors: essner r. J Clin Oncol. 1993 Sep;11(9):1751-6. doi: 10.1200/JCO.1993.11.9.1751. J Clin Oncol. 1993. PMID: 8355042

10

Surgical resection for melanoma metastatic to the gastrointestinal tract.

Ollila DW, Essner R, Wanek LA, Morton DL. Ollila DW, et al. Among authors: essner r. Arch Surg. 1996 Sep;131(9):975-9; 979-80. doi: 10.1001/archsurg.1996.01430210073013. Arch Surg. 1996. PMID: 8790168

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters